At present, detection of lung adenocarcinoma relies to a large extent on imaging procedures such as chest X-rays and CT scans, and only a few blood markers such as carcinoembryonic antigen have been developed for diagnosis of lung adenocarcinoma, while their sensitivity and specificity are unsatisfactory for routine clinical use3. This evidence concerns the gene CEACAM5 and lung adenocarcinoma.